You are searching for: COVID-19

No Structure Available Drug Name Otilimab
Drug Type Monoclonal antibody
Drug Status Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
TTD Drug ID D04GWO Drug Info
No Structure Available Drug Name Sirukumab
Drug Type Monoclonal antibody
Drug Status Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
TTD Drug ID D03RIX Drug Info
No Structure Available Drug Name Clazakizumab
Drug Type Monoclonal antibody
Drug Status Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
TTD Drug ID D03UEO Drug Info
No Structure Available Drug Name rhACE2
Drug Type Protein/peptide drug
Drug Status Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
TTD Drug ID D0RB6L Drug Info
Drug Name PUL-042
Drug Type Protein/peptide drug
Drug Status Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
TTD Drug ID D0BR8X Drug Info
No Structure Available Drug Name Lopinavir + ritonavir + ribavirin + interferon beta-1b
Drug Type Combination drug
Drug Status Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
TTD Drug ID D0GW4K Drug Info
No Structure Available Drug Name Rintatolimod
Drug Type Protein/peptide drug
Drug Status Phase 1/2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
TTD Drug ID D0C5MT Drug Info
No Structure Available Drug Name Meplazumab
Drug Type Monoclonal antibody
Drug Status Phase 1/2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
TTD Drug ID D03EOF Drug Info
No Structure Available Drug Name TJ003234
Drug Type Monoclonal antibody
Drug Status Phase 1/2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
TTD Drug ID D02ZXK Drug Info
Drug Name Leflunomide
Drug Type Small molecular drug
Drug Status Phase 1 Trial
Disease Coronavirus Disease 2019 (COVID-19)
TTD Drug ID D06VRI Drug Info

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.